FDA
approval
· 2020-08-20
FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Solco Healthcare LLC)
Summary
The FDA approved a supplemental application for a generic fixed-dose combination tablet of lisinopril and hydrochlorothiazide by Solco Healthcare LLC.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LISINOPRIL AND HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS)